Yousif Capital Management LLC Has $7.35 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Yousif Capital Management LLC lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 17,249 shares of the company’s stock after selling 1,305 shares during the period. Yousif Capital Management LLC’s holdings in HCA Healthcare were worth $7,352,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Norges Bank acquired a new position in HCA Healthcare during the second quarter worth $1,152,408,000. Viking Global Investors LP raised its holdings in shares of HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares during the period. Nordea Investment Management AB grew its holdings in HCA Healthcare by 6.8% during the second quarter. Nordea Investment Management AB now owns 927,781 shares of the company’s stock worth $350,404,000 after purchasing an additional 59,163 shares during the period. LSV Asset Management raised its stake in HCA Healthcare by 0.4% in the second quarter. LSV Asset Management now owns 868,849 shares of the company’s stock valued at $332,856,000 after buying an additional 3,396 shares during the period. Finally, Schroder Investment Management Group boosted its stake in shares of HCA Healthcare by 1.9% during the 2nd quarter. Schroder Investment Management Group now owns 676,225 shares of the company’s stock worth $259,062,000 after acquiring an additional 12,515 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 25th. Royal Bank Of Canada increased their price target on shares of HCA Healthcare from $482.00 to $525.00 and gave the company an “outperform” rating in a report on Friday, December 19th. Bank of America boosted their price objective on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a report on Monday, October 27th. TD Cowen lifted their price target on HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a research report on Monday. Fourteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $479.00.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $474.06 on Thursday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $520.00. The stock has a market capitalization of $108.18 billion, a PE ratio of 18.32, a P/E/G ratio of 1.40 and a beta of 1.36. The business has a fifty day moving average price of $473.53 and a two-hundred day moving average price of $418.93.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the previous year, the firm earned $4.90 earnings per share. HCA Healthcare’s revenue for the quarter was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

Insider Activity at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.